Validity and Reliability of the PRAFAB
ConditionUrinary Incontinence
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAfyonkarahisar Health Sciences University
About this trial
PRAFAB assesses both the objective and subjective aspects of urinary incontinence. While differing from other questionnaires in this respect, it consists of only five questions. Today, there is a need for multidimensional and easy-to-use scales that can assess the effects of incontinence on quality of life. Therefore, the aim of this study is to conduct a Turkish validity and reliability study of the PRAFAB questionnaire in women with urinary incontinence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being 18 years of age or older
Have been diagnosed with urinary incontinence by a urologist
Be female
Disqualifiers
Being pregnant,
Being in the early postpartum period,
Have been diagnosed with bladder cancer, diabetic nephropathy, a history of central nervous system damage, congenital urological disorders, urinary tract infection, neurogenic bladder, severe cognitive impairment, and severe psychiatric illness.
Trial population
Participants aged 18 years and older with female urinary incontinence will be included in the study. Participants will consist of women who visit the AFSU Health Application and Research Center Urology Outpatient Clinic and are diagnosed with urinary incontinence by a urologist.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Construct validity
Other interventionThis is not an intervention. This is an analysis conducted to examine the factor structure of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Test-retest reliability
Other interventionThis is not an intervention. This is an analysis conducted to examine the repeatability of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.
Treatment groups
63 Participants
are divided into 1 treatment groupGroup A: Urinary Incontinence2 interventions
Trial outcomes
Primary outcomes
1
PRAFAB
It is a 5-item questionnaire. Developed to assess the severity of urinary incontinence and its impact on the individual.
Time frame
This questionnaire, which takes approximately 2-3 minutes to complete, will be administered to participants twice at two-week intervals.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov